Rare diseases
Investigational molecules
Locations
Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy of NT 201 compared to placebo in adults with moderate to severe platysma prominence
GermanyStudy on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus
GermanyStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
GermanyStudy on the Effects of Barzolvolimab for Patients with Prurigo Nodularis
GermanyStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
GermanyStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
